We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Back to college usually means meningitis vaccine marketing, and that's exactly what GlaxoSmithKline is doing. It recently boosted its meningitis B awareness push with a second animated commercial added to the rotation for a campaign begun in 2018.
OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial.